Voyager Therapeutics, Inc.
MX ˙ BMV ˙ US92915B1061
SecurityMX:VYGR / Voyager Therapeutics, Inc.
InstitutionFiduciary Trust Co
Latest Disclosed Ownership334,397 shares
Latest Disclosed Value $ 1,290,772
Fiduciary Trust Co ownership in VYGR / Voyager Therapeutics, Inc.

On May 15, 2026 - Fiduciary Trust Co filed a 13F-HR form disclosing ownership of 334,397 shares of Voyager Therapeutics, Inc. (MX:VYGR) valued at $1,290,772 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 334,397 shares of Voyager Therapeutics, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 334,397 0 0.00 1,291 -1.83 0.0089
2026-02-13 2025-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 334,397 0 0.00 1,314 -15.82 0.0149
2025-11-14 2025-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 334,397 75,000 28.91 1,562 93.67 0.0177
2025-08-14 2025-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 259,397 0 0.00 807 -7.99 0.0099
2025-05-15 2025-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 259,397 0 0.00 877 -40.41 0.0115
2025-02-14 2024-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 259,397 0 0.00 1,471 -3.10 0.0194
2024-11-14 2024-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 259,397 0 0.00 1,517 -26.04 0.0212
2024-08-14 2024-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 259,397 0 0.00 2,052 -15.04 0.0308
2024-05-14 2024-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 259,397 0 0.00 2,415 10.28 0.0371
2024-02-12 2023-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 259,397 0 0.00 2,189 8.91 0.0366
2023-11-14 2023-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 259,397 3,837 1.50 2,010 -31.31 0.0368
2023-08-01 2023-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 255,560 3,257 1.29 2,926 50.44 0.0516
2023-05-15 2023-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 252,303 3,774 1.52 1,945 28.30 0.0361
2023-02-14 2022-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 248,529 0 0.00 1,516 3.06 0.0295
2022-11-14 2022-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 248,529 0 0.00 1,471 0.14 0.0318
2022-08-12 2022-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 248,529 0 0.00 1,469 -22.44 0.0309
2022-05-12 2022-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 248,529 0 0.00 1,894 181.01 0.0340
2022-02-14 2021-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 248,529 0 0.00 674 3.06 0.0111
2021-11-12 2021-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 248,529 93,186 59.99 654 1.87 0.0116
2021-08-16 2021-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 155,343 0 0.00 642 -12.30 0.0124
2021-05-19 2021-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 155,343 0 0.00 732 -34.11 0.0149
2021-01-26 2020-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 155,343 0 0.00 1,111 -32.99 0.0232
2020-11-13 2020-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 155,343 0 0.00 1,658 -15.41 0.0391
2020-08-13 2020-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 155,343 0 0.00 1,960 37.93 0.0485
2020-05-15 2020-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 155,343 0 0.00 1,421 -34.43 0.0412
2020-02-04 2019-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 155,343 0 0.00 2,167 -18.93 0.0505
2019-11-12 2019-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 155,343 0 0.00 2,673 -36.78 0.0671
2019-08-14 2019-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 155,343 0 0.00 4,228 42.21 0.1109
2019-05-07 2019-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 155,343 0 0.00 2,973 103.63 0.0799
2019-01-29 2018-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 155,343 0 0.00 1,460 -50.32 0.0447
2018-11-13 2018-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 155,343 772 0.50 2,939 -2.68 0.0825
2018-08-03 2018-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 154,571 772 0.50 3,020 4.50 0.0914
2018-05-07 2018-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 153,799 44,765 41.06 2,890 59.67 0.0893
2018-01-29 2017-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 109,034 0 0.00 1,810 -19.38 0.0538
2017-11-02 2017-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 109,034 0 0.00 2,245 129.79 0.0691
2017-08-09 2017-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 109,034 473 0.44 977 -32.01 0.0300
2017-05-15 2017-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 108,561 17,386 19.07 1,437 23.67 0.0439
2017-02-14 2016-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 91,175 0 0.00 1,162 6.12 0.0377
2016-11-14 2016-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 91,175 91,175 1,095 0.0375
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.